EBUS/Spectrum Analysis

Spectrum Image Analysis of Lymph Nodes During Endobronchial Ultrasound-Guided (EBUS) Transbronchial Needle Aspiration (TBNA) in Patients With Lung Cancer

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01972386

Enrollment

122

Registered

2013-10-30

Start date

2013-09-30

Completion date

2016-01-31

Last updated

2018-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Brief summary

To evaluate the clinical benefit of spectrum analysis of endobronchial ultrasound images of lymph nodes during EBUS TBNA for lymph node staging in patients with lung cancer.

Interventions

DEVICESpectrum Image Analysis using a Linear Array Ultrasound Bronchoscope

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Ages 18 years or older * Patients with known or suspected lung cancer who require EBUS-TBNA for lymph node staging

Exclusion criteria

* Patients who are deemed on clinical grounds not to be medically fit for a bronchoscopy * Inability to give informed consent * Patients who are pregnant

Design outcomes

Primary

Measure	Time frame	Description
Lymph Node Staging	Pathology report will be completed as soon as possible after the procedure. (Within one year)	The lymph node staging will be determined by the pathology report of the biopsy taken from the patients lymph node(s).

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026